reclassified 12 of them as Category 1 substances, the first regulatory step toward adding them to be compounded by pharmacies
Sequential measurements were made of muscle strength (one repetition maximum), body composition (dual energy x-ray absorptiometry), and circulating levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3
Instead of relying on appetite or irregular eating patterns, building a simple daily structure can help support more balanced intake throughout the day
The growing use of GLP-1 drugs in clinical practice makes these findings particularly significant
And crucially, such advances are entirely possible through the adoption of modern digital monitoring techniques
doi: 10.1053/j.gastro.2007.03.054 [PubMed] [CrossRef] [Google Scholar] Mathiesen D.S., et al., The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A Review